Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha ...

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Amgen (AMGN – Research Report), with a price target of ...

Amgen and UCB have suffered another setback as they try to build momentum for Evenity, their new antibody therapy for osteoporosis. The EMA’s Committee for Medicinal Products for Human Use (CHMP ...

At the heart of the dispute is whether Amgen's claims are ... court's view that companies that prove the commercial viability of products should not be penalized by small and inconclusive clinical ...

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer The UK’s Medicines and Healthcare products Regulatory Agency (MHRA ... Executive Medical Director, Amgen UK & Ireland ...

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular ... next-generation products, Aranesp and ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.